ABSTRACT
INTRODUCTION
Ovarian cancer is a commonly diagnosed and a deadly gynaecological malignancy worldwide. This type of cancer is ranked as the top ten diagnosed cancer and deadliest cancer among women in the world. It is estimated that a total of 238,700 new cases of ovarian cancer have been reported worldwide in 2012. Based on this 2012 report, 99,800 of new cases were reported in more developed regions, 139,000 of the cases being reported in less developed regions and 111,900 of the cases have been reported in Asia (Ferlay et al. 2015) .
In 2007, ovarian cancer is the fourth most common cancer among female in Malaysia with a total of 656 cases been diagnosed. It ranked as the third most common cancer among female in Kelantan with a total of 40 cases were diagnosed during the same year (Zainal Ariffin & Nor Saleha 2011) ( Table 1) .
The five year survival rate varies greatly across the country. The patients in developed country reported higher five year survival rate compared with those in developing country. For example, a developed country such as Singapore reported higher five year survival rate (62%) compared to a developing country such as Thailand with 47% five year survival rate. This situation showed that high advancement in medical services and availability of diagnostic facilities may lead to a better survival rate (Wong et al. 2012 ).
Ovarian cancer is well known as a 'silent killer' disease. The disease is usually asymptomatic during early stage causes more than two third of the patients only been diagnosed during advanced stage where the chances of cure is poorer compared to less advanced stage cancer (Goff et al. 2004; Ozols 2005) . One study by Bankhead et al. (2005) found that most patients were facing difficulty to identify the symptoms of ovarian cancer; They had mistakenly assuming the symptoms as a normal changes in the body due to the effect of child bearing, menopause or ageing (Bankhead et al. 2005) .
The prognostic factors of ovarian cancer were varies across different study. Some report have found out that younger women with early stage ovarian cancer and better differentiated tumours had higher survival probability compared to older women. However, other study had found out that age was not the independent prognostic factor after adjusting for other variables such as stage and grade of disease (Chan et al. 2008) .
Since there is inconsistent prognostic factor of ovarian cancer across different study, this study was conducted to identify the real prognostic factors of ovarian cancer after adjusting for potential cofounders. The aim of this study was to determine the median survival time, five year survival probability and the prognostic factor of ovarian cancer. This study was conducted in Malaysian population, with different ethnic group where the cultural, geographical, belief and lifestyle here are different with other country in the world. Thus, the results from this study were expected to give some positive impact to reduce mortality rate among patients with ovarian cancer in Malaysia.
METHODS STUDY DESIGN AND PARTICIPANTS
This study was a retrospective cohort study using patient record review. All ovarian cancer patients registered in one of the teaching hospital in Malaysia (Hospital Universiti Sains Malaysia) from 1st January 2002 until 31st December 2011 were recruited in the study. There was an additional one year follow-up period after the recruitment phase to determine patients' survival status especially for those who were recruited at the end of study.
Sample size was calculated using PS Power software. The reference to calculate the sample size was referred from a study by Tingulstad et al. (2003) using the size of residual disease variable. The calculated sample size in this study was 141 patients. However, only 127 patients were selected after considering the inclusion and exclusion criteria (Figure 1) The Kaplan-Meier Survival Analysis was used to determine the overall 5-years survival probability and median survival time of ovarian cancer. The Cox Proportional Hazard Regression analysis was used to identify the prognostic factor of ovarian cancer (Table 2) .
RESULTS

SOCIO-DEMOGRAPHIC OF THE SUBJECTS
There were 127 patients' medical records included in this study after considering the inclusion and exclusion criteria. The main endpoint of this study was death among 78 (61.4%) patients while other 49 (38.6%) patients were censored observations. Censored observations were patients who are still survive at the end of maximum follow up period, died due to other causes and lost to followup. The overall mean age was 47.8 (SD 15.5) years with majority of the patients were Malay (89.0%) compared to non-Malay (11.0%). Majority of the patients were married (59.8%), some were divorced/widow (16.5%) and single (23.6%). 
PROGNOSTIC FACTORS OF OVARIAN CANCER
The variables that were selected in this study were categorized into three main categories that are patientrelated characteristics, disease-related characteristics and treatment-related characteristics. From Simple Cox Proportional Hazard Regression Analysis, four variables from patient-related characteristics, seventeen variables from disease-related characteristics and three variables form treatment-related characteristics had significant value less than 0.25 and were considered as potential prognostic factors (Table 3) . These variables were then analysed with Multiple Cox Proportional Hazard Regression Analysis to confirm the prognostic factor of the study. Three significant prognostic factors for ovarian cancer found were stage at diagnosis, loss of appetite and presence of pleural effusion. The findings are as follow: Ovarian cancer patients who were in advanced stage during diagnosis are 2.53 times higher risk (HR: 2.53; 95% CI: 1.44, 4.45) to die from ovarian cancer compared with those in early stage cancer during diagnosis; Ovarian cancer patients who had symptom loss of appetite before the diagnosis of ovarian cancer are 95% higher risk (HR: 1.95; 1.23, 3.11) to die from ovarian cancer compared with those who did not experience loss of appetite; and Ovarian cancer patients who had pleural effusion were 98% higher risk (HR: 1.98; 1.19, 3.30) to die from ovarian cancer compared with those who did not had pleural effusion (Table 4) .
The assumption checking was done, showed that there was no possible interaction and correlation present between significant variables. The powerful assumption checking was done by global test showed a non-significant result (p=0.325). This showed that the proportional hazard assumption for survival analysis was met. The result from global test showed that hazard is proportional over time and hazard ratio is constant over time.
DISCUSSION
The result from current study showed that the overall five year survival probability was 35.2% with median survival time 38 months. This findings were almost similar with previous study that was conducted among 480 incident cases of ovarian cancer in Norway with five-year survival probability of 39% and another study among 3482 women with epithelial ovarian cancer treated in general hospital in Netherland also showed five-year survival probability of 38% (Tingulstad et al. 2003; Vernooij et al. 2008) . Nicholson et al. (1998) concluded that in general the overall five-year survival probability of ovarian cancer was around 30%.
In this study, cancer stage showed a significant value with the hazard ratio of 2.53. As compared with other studies, this study showed a lower hazard ratio. A study from Wong et al. (2012) in Hong Kong found that the hazard ratio increase to 9.7 for stage four ovarian cancer 1997-2006 1993-1997 1993-2001 1995-1997 1990-2000 1990-2000 53.1 (60.8,65.5) 62 59(52-64) 60 47(45-58) 25(19-29) (Wong et al. 2012) Forward stepwise was applied. Two-way interaction and multicollinearity problem were checked and not detected. Proportional hazard assumption were fulfilled (hazard function plot, log-minus-log plot and Schoenfeld residual were checked) Regression diagnostic of Cox-Snell residual, Martingale residuals, deviance residuals and influential analysis were assessed. Remedial measure were perform to identify any influential outliers based on 20% changes of regression coefficients. and Tingulstad et al. (2003) in Norway also obtained higher hazard ratio of 11.8 for stage four ovarian cancers compared to stage one cancer (Table 5) . A possible explanation for a lower hazard ratio in this study compared to other significant studies might happen when the patients from early stage during diagnosis developed to the advance stage throughout the treatment process. This situation will affect the survival probability and lead to the slight difference in hazard ratio between early and advanced stage cancer. The loss of appetite was found to be a significant prognostic factor of ovarian cancer. It was found that patients that developed this symptom had almost double risk to death compared to the patients who did not presence with this symptom. This finding was supported by a study from Quinten et al. (2009) using 10108 cancer patients in Europe that discovered that loss of appetite was the significant prognostic factor of survival with the hazard ratio of 1.05 (95%CI:1.03,1.06).
This current study identified that patients who had pleural effusion were 3.19 times higher risk to die from ovarian cancer compared with other patients who did not have pleural effusion. This finding seem to be consistent with other research which found out that patients who experienced pleural metastases were 50% more likely to die compared to other patients who experienced lymph node or other site metastases (Bonnefoi et al. 1999) . Another retrospective study from Zamboni et al. (2015) from 2000 to 2011 towards 165 malignant pleural effusion in Brazil found that the ovary tumour is the significant prognostic factor among patients with malignant pleural effusions with the median survival time of 21 months.
There are a few strength and limitations in this study. The usage of survival analysis is the best choice in analysing time to event data where the analysis account for censored data, and manage to handle data with subjects entering the study at different time. The survival analysis also can compare survival between groups and able to assess relationship between covariates and survival time.
However, this study did not fulfil the required number of sample size (n=144). After considering the inclusion and exclusion criteria, the researcher only manage to obtain the total number of 127 subjects. However, the number of sample size is still acceptable since the insufficient sample size is less than 30% with the post hoc power of the study is 78.7%.
In this study, some of the potential prognostic factors that have been reported previously in other study such as chemotherapy regime, laboratory findings, weight, duration of treatment and age at menarche were not considered because the data about these variables were vague, incomplete and unavailable in most of the patients' record. Thus, to avoid these missing values from altered the findings of the study, the variables were excluded from the analysis.
CONCLUSION
Overall, the survival of ovarian cancer was worrying with the low percentage. In this study, three significant prognostic factor were found to be significant in this study with the average hazard ratio almost double compared to low risk group. Thus, the prospective cohort study needs to be done to discover more effective and accurate test for early detection of ovarian cancer. Therefore, people are able to come at earlier stage before the symptoms of ovarian cancer such as loss of appetite and pleural effusion arises. This will give a better survival outcome to ovarian cancer patients and reduce mortality rate. 1.0 2.7(1.9,3.7) 5.9(4.7,7.5) 9.7(7.5,12.7) O'Malley et al. (2003) Nothern California 1 2 3 4 1.0 3.4(1.9,6.0) 8.0(4.8,13.5) 11.8(6.9,20.0) Tingulstad et al. (2003) Norway 1 2 3 4 1 4.3(2.51,7.2) 8. 03(5.04,12.8) 11.8(7.0,19.8) (Wong et al. 2012; O'Malley et al. 2003; Tingulstad et al. 2003) for her contribution in proof reading. Lastly, we would like to thank all medical record staff that involved during the data collection stage.
